BRIACELL THERAPEUTICS CORP. : Results of Operations and Fina

Item 2.02 Results of Operations and Financial Condition.

The information in Item 7.01 below is incorporated herein by reference.

The information in this Item 2.02 shall not be deemed filed for... | October 28, 2022

Related Keywords

United States , , National Instrument , International Financial Reporting Standards , Briacell Therapeutics Corp , Company Annual Report On Form , Exchange Commission , Securities Exchange , International Accounting Standards Board , Securities Exchange Act , Securities Act , Exchange Act , Cell Therapeutics , Annual Report , Disclosure Obligations , Interim Financial Statements , Restated Interim Financial Statements , Original Interim Financial Statements , Current Report , Edgar Online , Briacell Therapeutics Corp Stock Exchange , News , Information , Press Release , Item , Results , F , Operations , End , Financial , N , Elow , Us , Ncorporated , Wherein , Y , This , Hall , Lot , The , Neemed , Iled Bct Ca10778y3023 ,